Wugen
Wugen is a clinical-stage biotechnology company developing a pipeline of allogeneic cell therapies to treat a broad range of hematological and solid tumor malignancies.
Year Established: 2018
Stock Ticker:
Exchange:
Locations
Wugen
St. Louis MOWugen is a clinical-stage biotechnology company developing a pipeline of allogeneic cell therapies to treat a broad range of hematological and solid tumor malignancies.
Wugen
San Diego CAWugen is a clinical-stage biotechnology company developing a pipeline of allogeneic cell therapies to treat a broad range of hematological and solid tumor malignancies.
